Current investigation and management of patients with syncope: Results of the European heart rhythm association survey

Europace

Volumn 15, Issue 12, 2013, Pages 1812-1815

  Dagres, Nikolaos ^a   Bongiorni, Maria Grazia ^b   Dobreanu, Dan ^c   Madrid, Antonio ^d   Svendsen, Jesper Hastrup ^e   Blomström Lundqvist, Carina ^f  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

EHRA survey; EP wire; Syncope; Syncope unit; Tilt test

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; MIDODRINE; SEROTONIN UPTAKE INHIBITOR;

AGE; CAROTID SINUS MASSAGE; COMORBIDITY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FAINTNESS; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART PACING; HOLTER MONITORING; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIAC MONITOR; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; REVIEW; TILT TABLE TEST;

EHRA SURVEY; EP WIRE; SYNCOPE; SYNCOPE UNIT; TILT TEST;

ALGORITHMS; ARGENTINA; CRITICAL PATHWAYS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EUROPE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HOSPITAL UNITS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SYNCOPE; TIME FACTORS;

EID: 84890451223     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut354     Document Type: Review

References (16)

1. Sheldon RS, Morillo CA, Krahn AD, O'Neill B, Thiruganasambandamoorthy V, Parkash R et al. Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper. Can J Cardiol 2011;27:246-53.
2. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.
3. Brignole M, Hamdan MH. New concepts in the assessment of syncope. J Am Coll Cardiol 2012;59:1583-91.
4. Costantino G, Furlan R. Syncope risk stratification in the emergency department. Cardiol Clin 2013;31:27-38.
5. Daccarett M, Jetter TL, Wasmund SL, Brignole M, Hamdan MH. Syncope in the emergency department: comparison of standardized admission criteria with clinical practice. Europace 2011;13:1632-8.
6. Brignole M, Hamdan MH. A standardized guideline-based algorithm coupled with online decision-making tool: the new frontier for efficient management of syncope Europace 2011;13:1359-61.
7. Sanders NA, Jetter TL, Brignole M, Hamdan MH. Standardized care pathway versus conventional approach in the management of patients presenting with faint at the University of Utah. Pacing Clin Electrophysiol 2013;36:152-62.
8. Mitro P, Kirsch P, Valocik G, Muŕn P. A prospective study of the standardized diagnostic evaluation of syncope. Europace 2011;13:566-71.
9. Fedorowski A, Burri P, Juul-Mö ller S, Melander O. A dedicated investigation unit improves management of syncopal attacks (Syncope Study of Unselected Population in Malmo-SYSTEMA I). Europace 2010;12:1322-8.
10. Edvardsson N, Frykman V, van Mechelen R, Mitro P, Mohii-Oskarsson A, Pasquié JL et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace 2011;13:262-9.
11. Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 2009; 11:671-87.
12. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sánchez A et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebocontrolled study. J Am Coll Cardiol 2001;37:554-9.
13. Romme JJ, van Dijk N, Go-Schön IK, Reitsma JB, WielingW. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to nonpharmacological treatment (STAND-trial). Europace 2011;13:1639-47.
14. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013;15:1070-118.
15. Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012;125:2566-71.
16. http://www.escardio.org/about/press/press-releases/pr-13/Pages/ europace-2013-late-breaking-trials-two.aspxhit=dontmiss (1 October 2013, date last accessed).